|
|
|
|
|
by llm_nerd
126 days ago
|
|
It was a tiny study, and one arm had someone dropout because they had COVID. The difference was minuscule. You are being bizarrely selective in discarding the part you don't like, while holding the rest as demonstrative. "But I think that prediction would be quite unusual." Would it? Who in the world would guess that small ramp-up doses of a semaglutide (0.25, 0.5, and 1mg, the first two doses over 89% of the study duration. The average maintenance dose is 2.4mg) would immediately undo long-earned core habits over just two months? It's a rather absurd study. |
|